The Meaning of Dopaminergic Pathway in Sleep Breathing Disorders.
Launched by WROCLAW MEDICAL UNIVERSITY · May 25, 2023
Trial Information
Current as of July 23, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Sleep-disordered breathing (SDB) refers to a spectrum of abnormalities related to sleep. Obstructive sleep apnea (OSA) is the most common type of SDB and affects approximately one billion adults worldwide. Untreated OSA leads to significant comorbidities and increased mortality due to significantly increased risk of stroke and heart attack. Because of limited access to objective sleep studies and the fact that untreated OSA is a real risk factor premature death, the determination of possible organic reasons for its occurrence is a key aspect. The purpose of the study is to determine the imp...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age between 18 and 80 years old
- • suspicion of sleep-disordered breathing
- Exclusion Criteria:
- • age under 18
- • age over 80
- • severe disorders and systemic diseases (including genetical disorders)
- • neurological disorders
- • active inflammations
- • active cancer
- • severe mental disorders and retardation (including genetical)
- • taking drugs that could falsify polysomnography
- • confirmed alcoholism
- • drug addiction
- • pregnancy and breast feeding
- • treatment using or dependence on any painkillers and/or drugs and substances that may affect nervous, muscular and respiratory system functions
- • lack of consent to participate in the study
About Wroclaw Medical University
Wrocław Medical University is a prestigious academic institution located in Wrocław, Poland, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive expertise in healthcare and biomedical sciences to facilitate innovative research initiatives aimed at improving patient outcomes. With a strong emphasis on ethical practices and regulatory compliance, Wrocław Medical University collaborates with a diverse network of healthcare professionals and researchers to conduct rigorous clinical trials that contribute to the development of new therapies and enhance the understanding of various medical conditions. Its dedication to scientific excellence and patient safety positions the university as a key player in the global clinical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Wroclaw, , Poland
Patients applied
Trial Officials
Joanna Smardz, Ph.D
Principal Investigator
Wroclaw Medical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported